Compare Stocks

4 / 10
Try these comparisons:

Stock Comparison

ARDT vs CYH vs HCA vs THC

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
ARDT
Ardent Health Partners, LLC

Medical - Care Facilities

HealthcareNYSE • US
Market Cap$1.41B
5Y Perf.-44.7%
CYH
Community Health Systems, Inc.

Medical - Care Facilities

HealthcareNYSE • US
Market Cap$408M
5Y Perf.-45.0%
HCA
HCA Healthcare, Inc.

Medical - Care Facilities

HealthcareNYSE • US
Market Cap$95.95B
5Y Perf.+18.2%
THC
Tenet Healthcare Corporation

Medical - Care Facilities

HealthcareNYSE • US
Market Cap$17.01B
5Y Perf.+29.7%

ARDT vs CYH vs HCA vs THC — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
ARDT logoARDT
CYH logoCYH
HCA logoHCA
THC logoTHC
IndustryMedical - Care FacilitiesMedical - Care FacilitiesMedical - Care FacilitiesMedical - Care Facilities
Market Cap$1.41B$408M$95.95B$17.01B
Revenue (TTM)$6.43B$21.48B$75.60B$21.45B
Net Income (TTM)$134M$-88M$6.78B$1.70B
Gross Margin60.5%53.7%41.5%42.8%
Operating Margin8.9%-39.8%15.8%16.1%
Forward P/E8.7x0.8x14.2x10.9x
Total Debt$2.26B$11.58B$50.20B$13.17B
Cash & Equiv.$710M$260M$1.04B$2.88B

ARDT vs CYH vs HCA vs THCLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

ARDT
CYH
HCA
THC
StockJul 24May 26Return
Ardent Health Partn… (ARDT)10055.3-44.7%
Community Health Sy… (CYH)10055.0-45.0%
HCA Healthcare, Inc. (HCA)100118.2+18.2%
Tenet Healthcare Co… (THC)100129.7+29.7%

Price return only. Dividends and distributions are not included.

Quick Verdict: ARDT vs CYH vs HCA vs THC

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: HCA leads in 5 of 7 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. Community Health Systems, Inc. is the stronger pick specifically for valuation and capital efficiency. THC also leads in specific categories worth noting. As sector peers, any of these can serve as alternatives in the same allocation.
ARDT
Ardent Health Partners, LLC
The Defensive Pick

ARDT is the clearest fit if your priority is sleep-well-at-night.

  • Lower volatility, beta 1.40, current ratio 1.97x
Best for: sleep-well-at-night
CYH
Community Health Systems, Inc.
The Value Play

CYH is the #2 pick in this set and the best alternative if value is your priority.

  • Lower P/E (0.8x vs 14.2x)
Best for: value
HCA
HCA Healthcare, Inc.
The Income Pick

HCA carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.

  • Dividend streak 5 yrs, beta 0.29, yield 0.7%
  • Rev growth 7.1%, EPS growth 29.0%, 3Y rev CAGR 7.9%
  • 7.1% revenue growth vs CYH's -1.2%
  • 9.0% margin vs CYH's -0.4%
Best for: income & stability and growth exposure
THC
Tenet Healthcare Corporation
The Long-Run Compounder

THC is the clearest fit if your priority is long-term compounding and valuation efficiency.

  • 5.2% 10Y total return vs HCA's 450.5%
  • PEG 0.33 vs HCA's 0.67
  • Beta 0.71, current ratio 1.76x
  • +27.4% vs ARDT's -30.5%
Best for: long-term compounding and valuation efficiency
See the full category breakdown
CategoryWinnerWhy
GrowthHCA logoHCA7.1% revenue growth vs CYH's -1.2%
ValueCYH logoCYHLower P/E (0.8x vs 14.2x)
Quality / MarginsHCA logoHCA9.0% margin vs CYH's -0.4%
Stability / SafetyHCA logoHCABeta 0.29 vs CYH's 1.60
DividendsHCA logoHCA0.7% yield; 5-year raise streak; the other 3 pay no meaningful dividend
Momentum (1Y)THC logoTHC+27.4% vs ARDT's -30.5%
Efficiency (ROA)HCA logoHCA11.3% ROA vs CYH's -0.7%, ROIC 19.9% vs -70.1%

ARDT vs CYH vs HCA vs THC — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

ARDTArdent Health Partners, LLC
FY 2025
Reportable Segment
100.0%$6.3B
CYHCommunity Health Systems, Inc.
FY 2025
Managed Care And Other Third Party Payors
58.4%$6.0B
Medicare
21.2%$2.2B
Medicaid
19.5%$2.0B
Self Pay Revenue
0.9%$96M
HCAHCA Healthcare, Inc.
FY 2025
Managed Care And Other Insurers
50.5%$37.0B
Managed Medicare
18.4%$13.4B
Medicare
15.4%$11.3B
Medicaid
8.1%$5.9B
Managed Medicaid
5.0%$3.7B
International
2.5%$1.9B
THCTenet Healthcare Corporation
FY 2025
Ambulatory Care
50.2%$5.2B
Hospital Operations
49.8%$5.1B

ARDT vs CYH vs HCA vs THC — Financial Metrics

Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLTHCLAGGINGCYH

Income & Cash Flow (Last 12 Months)

THC leads this category, winning 3 of 6 comparable metrics.

HCA is the larger business by revenue, generating $75.6B annually — 11.8x ARDT's $6.4B. HCA is the more profitable business, keeping 9.0% of every revenue dollar as net income compared to CYH's -0.4%.

MetricARDT logoARDTArdent Health Par…CYH logoCYHCommunity Health …HCA logoHCAHCA Healthcare, I…THC logoTHCTenet Healthcare …
RevenueTrailing 12 months$6.4B$21.5B$75.6B$21.5B
EBITDAEarnings before interest/tax$733M-$7.8B$15.5B$4.3B
Net IncomeAfter-tax profit$134M-$88M$6.8B$1.7B
Free Cash FlowCash after capex$214M-$200M$7.7B$3.3B
Gross MarginGross profit ÷ Revenue+60.5%+53.7%+41.5%+42.8%
Operating MarginEBIT ÷ Revenue+8.9%-39.8%+15.8%+16.1%
Net MarginNet income ÷ Revenue+2.1%-0.4%+9.0%+7.9%
FCF MarginFCF ÷ Revenue+3.3%-0.9%+10.2%+15.6%
Rev. Growth (YoY)Latest quarter vs prior year+7.0%+2.8%+6.7%+2.8%
EPS Growth (YoY)Latest quarter vs prior year-3.4%-45.2%+44.6%+87.6%
THC leads this category, winning 3 of 6 comparable metrics.

Valuation Metrics

Evenly matched — ARDT and CYH each lead in 3 of 7 comparable metrics.

At 0.8x trailing earnings, CYH trades at a 95% valuation discount to HCA's 15.1x P/E. Adjusting for growth (PEG ratio), THC offers better value at 0.38x vs HCA's 0.72x — a lower PEG means you pay less per unit of expected earnings growth.

MetricARDT logoARDTArdent Health Par…CYH logoCYHCommunity Health …HCA logoHCAHCA Healthcare, I…THC logoTHCTenet Healthcare …
Market CapShares × price$1.4B$408M$95.9B$17.0B
Enterprise ValueMkt cap + debt − cash$3.0B$11.7B$145.1B$27.3B
Trailing P/EPrice ÷ TTM EPS10.29x0.77x15.12x12.53x
Forward P/EPrice ÷ next-FY EPS est.8.65x14.19x10.94x
PEG RatioP/E ÷ EPS growth rate0.72x0.38x
EV / EBITDAEnterprise value multiple6.17x9.37x6.34x
Price / SalesMarket cap ÷ Revenue0.22x0.03x1.27x0.80x
Price / BookPrice ÷ Book value/share0.83x1.97x
Price / FCFMarket cap ÷ FCF5.47x1.96x12.47x6.72x
Evenly matched — ARDT and CYH each lead in 3 of 7 comparable metrics.

Profitability & Efficiency

Evenly matched — ARDT and HCA each lead in 4 of 9 comparable metrics.

THC delivers a 19.6% return on equity — every $100 of shareholder capital generates $20 in annual profit, vs $8 for ARDT. ARDT carries lower financial leverage with a 1.34x debt-to-equity ratio, signaling a more conservative balance sheet compared to THC's 1.47x. On the Piotroski fundamental quality scale (0–9), HCA scores 7/9 vs CYH's 6/9, reflecting strong financial health.

MetricARDT logoARDTArdent Health Par…CYH logoCYHCommunity Health …HCA logoHCAHCA Healthcare, I…THC logoTHCTenet Healthcare …
ROE (TTM)Return on equity+8.0%+19.6%
ROA (TTM)Return on assets+2.6%-0.7%+11.3%+5.7%
ROICReturn on invested capital+7.5%-70.1%+19.9%+13.2%
ROCEReturn on capital employed+7.9%-87.3%+27.0%+13.8%
Piotroski ScoreFundamental quality 0–96677
Debt / EquityFinancial leverage1.34x1.47x
Net DebtTotal debt minus cash$1.6B$11.3B$49.2B$10.3B
Cash & Equiv.Liquid assets$710M$260M$1.0B$2.9B
Total DebtShort + long-term debt$2.3B$11.6B$50.2B$13.2B
Interest CoverageEBIT ÷ Interest expense6.36x4.89x5.37x4.28x
Evenly matched — ARDT and HCA each lead in 4 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

THC leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in THC five years ago would be worth $29,044 today (with dividends reinvested), compared to $1,902 for CYH. Over the past 12 months, THC leads with a +27.4% total return vs ARDT's -30.5%. The 3-year compound annual growth rate (CAGR) favors THC at 40.7% vs ARDT's -15.0% — a key indicator of consistent wealth creation.

MetricARDT logoARDTArdent Health Par…CYH logoCYHCommunity Health …HCA logoHCAHCA Healthcare, I…THC logoTHCTenet Healthcare …
YTD ReturnYear-to-date+14.4%-6.6%-8.6%-2.7%
1-Year ReturnPast 12 months-30.5%-11.7%+19.7%+27.4%
3-Year ReturnCumulative with dividends-38.5%-16.8%+57.4%+178.5%
5-Year ReturnCumulative with dividends-38.5%-81.0%+109.7%+190.4%
10-Year ReturnCumulative with dividends-38.5%-80.3%+450.5%+523.4%
CAGR (3Y)Annualised 3-year return-15.0%-6.0%+16.3%+40.7%
THC leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

Evenly matched — HCA and THC each lead in 1 of 2 comparable metrics.

HCA is the less volatile stock with a 0.29 beta — it tends to amplify market swings less than CYH's 1.60 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. THC currently trades 78.5% from its 52-week high vs ARDT's 63.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricARDT logoARDTArdent Health Par…CYH logoCYHCommunity Health …HCA logoHCAHCA Healthcare, I…THC logoTHCTenet Healthcare …
Beta (5Y)Sensitivity to S&P 5001.40x1.60x0.29x0.71x
52-Week HighHighest price in past year$15.48$4.47$556.52$247.21
52-Week LowLowest price in past year$8.07$2.38$330.00$146.60
% of 52W HighCurrent price vs 52-week peak+63.8%+64.8%+77.1%+78.5%
RSI (14)Momentum oscillator 0–10046.646.430.852.9
Avg Volume (50D)Average daily shares traded382K1.6M1000K1.2M
Evenly matched — HCA and THC each lead in 1 of 2 comparable metrics.

Analyst Outlook

HCA leads this category, winning 1 of 1 comparable metric.

Analyst consensus: ARDT as "Buy", CYH as "Hold", HCA as "Buy", THC as "Buy". Consensus price targets imply 38.1% upside for THC (target: $268) vs 1.2% for CYH (target: $3). HCA is the only dividend payer here at 0.69% yield — a key consideration for income-focused portfolios.

MetricARDT logoARDTArdent Health Par…CYH logoCYHCommunity Health …HCA logoHCAHCA Healthcare, I…THC logoTHCTenet Healthcare …
Analyst RatingConsensus buy/hold/sellBuyHoldBuyBuy
Price TargetConsensus 12-month target$13.33$2.93$527.45$268.00
# AnalystsCovering analysts12374632
Dividend YieldAnnual dividend ÷ price+0.7%
Dividend StreakConsecutive years of raises1250
Dividend / ShareAnnual DPS$2.94
Buyback YieldShare repurchases ÷ mkt cap0.0%+0.5%+10.5%+8.4%
HCA leads this category, winning 1 of 1 comparable metric.
Key Takeaway

THC leads in 2 of 6 categories (Income & Cash Flow, Total Returns). HCA leads in 1 (Analyst Outlook). 3 tied.

Best OverallTenet Healthcare Corporation (THC)Leads 2 of 6 categories
Loading custom metrics...

ARDT vs CYH vs HCA vs THC: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is ARDT or CYH or HCA or THC a better buy right now?

For growth investors, HCA Healthcare, Inc.

(HCA) is the stronger pick with 7. 1% revenue growth year-over-year, versus -1. 2% for Community Health Systems, Inc. (CYH). Community Health Systems, Inc. (CYH) offers the better valuation at 0. 8x trailing P/E, making it the more compelling value choice. Analysts rate Ardent Health Partners, LLC (ARDT) a "Buy" — based on 12 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — ARDT or CYH or HCA or THC?

On trailing P/E, Community Health Systems, Inc.

(CYH) is the cheapest at 0. 8x versus HCA Healthcare, Inc. at 15. 1x. On forward P/E, Ardent Health Partners, LLC is actually cheaper at 8. 7x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Tenet Healthcare Corporation wins at 0. 33x versus HCA Healthcare, Inc. 's 0. 67x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

03

Which is the better long-term investment — ARDT or CYH or HCA or THC?

Over the past 5 years, Tenet Healthcare Corporation (THC) delivered a total return of +190.

4%, compared to -81. 0% for Community Health Systems, Inc. (CYH). Over 10 years, the gap is even starker: THC returned +523. 4% versus CYH's -80. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — ARDT or CYH or HCA or THC?

By beta (market sensitivity over 5 years), HCA Healthcare, Inc.

(HCA) is the lower-risk stock at 0. 29β versus Community Health Systems, Inc. 's 1. 60β — meaning CYH is approximately 460% more volatile than HCA relative to the S&P 500. On balance sheet safety, Ardent Health Partners, LLC (ARDT) carries a lower debt/equity ratio of 134% versus 147% for Tenet Healthcare Corporation — giving it more financial flexibility in a downturn.

05

Which is growing faster — ARDT or CYH or HCA or THC?

By revenue growth (latest reported year), HCA Healthcare, Inc.

(HCA) is pulling ahead at 7. 1% versus -1. 2% for Community Health Systems, Inc. (CYH). On earnings-per-share growth, the picture is similar: Community Health Systems, Inc. grew EPS 196. 7% year-over-year, compared to -52. 6% for Tenet Healthcare Corporation. Over a 3-year CAGR, HCA leads at 7. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — ARDT or CYH or HCA or THC?

HCA Healthcare, Inc.

(HCA) is the more profitable company, earning 9. 0% net margin versus 2. 1% for Ardent Health Partners, LLC — meaning it keeps 9. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: THC leads at 16. 1% versus -79. 4% for CYH. At the gross margin level — before operating expenses — ARDT leads at 97. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is ARDT or CYH or HCA or THC more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Tenet Healthcare Corporation (THC) is the more undervalued stock at a PEG of 0. 33x versus HCA Healthcare, Inc. 's 0. 67x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Ardent Health Partners, LLC (ARDT) trades at 8. 7x forward P/E versus 14. 2x for HCA Healthcare, Inc. — 5. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for THC: 38. 1% to $268. 00.

08

Which pays a better dividend — ARDT or CYH or HCA or THC?

In this comparison, HCA (0.

7% yield) pays a dividend. ARDT, CYH, THC do not pay a meaningful dividend and should not be held primarily for income.

09

Is ARDT or CYH or HCA or THC better for a retirement portfolio?

For long-horizon retirement investors, HCA Healthcare, Inc.

(HCA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 29), 0. 7% yield, +450. 5% 10Y return). Community Health Systems, Inc. (CYH) carries a higher beta of 1. 60 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (HCA: +450. 5%, CYH: -80. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between ARDT and CYH and HCA and THC?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

HCA pays a dividend while ARDT, CYH, THC do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

ARDT

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Gross Margin > 36%
Run This Screen
Stocks Like

CYH

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 142%
  • Gross Margin > 32%
Run This Screen
Stocks Like

HCA

Stable Dividend Mega-Cap

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 5%
Run This Screen
Stocks Like

THC

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Net Margin > 5%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform ARDT and CYH and HCA and THC on the metrics below

Revenue Growth>
%
(ARDT: 7.0% · CYH: 284.9%)
P/E Ratio<
x
(ARDT: 10.3x · CYH: 0.8x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.